Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001688199-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
8,331
Total Value
$355,217.47
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 2,777 | $18.36 | $50,985.72 | 2,777 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 70 | $107.11 | $7,497.70 | 2,707 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 737 | $108.17 | $79,721.29 | 1,970 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 831 | $108.95 | $90,537.45 | 1,139 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 272 | $109.96 | $29,909.12 | 867 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 470 | $111.05 | $52,193.50 | 397 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Sale | 397 | $111.77 | $44,372.69 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 2,777 | $0.00 | $0.00 | 22,223 | Direct | โ | View Details |